If you are asking what blood test shows kidney function, the answer is a creatinine test, almost always run as part of a basic or comprehensive metabolic panel, which gives three numbers worth reading: creatinine, the waste product your kidneys clear; eGFR, the filtration rate calculated from it; and BUN, a second waste marker that adds context. eGFR is the one clinicians act on. Two more tests complete the picture when it matters: a urine albumin test, which finds kidney damage before filtration drops, and cystatin C, which makes the estimate more accurate when creatinine is unreliable.

Key takeaways

  • Creatinine is measured; eGFR is calculated from it using your age and sex. eGFR is the number that stages kidney function, and 60 or above is the key threshold.
  • BUN is a supporting number. It rises with kidney trouble but also with dehydration and high-protein eating, so it is read next to creatinine, not alone.
  • Creatinine depends on muscle, so eGFR runs misleadingly low in muscular people and misleadingly high in frail ones. Cystatin C corrects for that.
  • A urine albumin-to-creatinine ratio catches kidney damage that blood tests miss, which is why NIDDK pairs it with eGFR for anyone at risk.
  • One low eGFR is not a diagnosis. Chronic kidney disease means reduced function or damage persisting for three months, confirmed on repeat.

What the kidneys do, and why one number cannot capture it

Your kidneys filter about half a cup of blood every minute, pulling out waste and excess water to make urine while keeping the proteins and cells your body needs. “Kidney function” in lab terms mostly means filtration: how much blood the tiny filters, the glomeruli, process per minute. The blood tests below are all ways of estimating that rate from the waste products that build up when it falls.

That is the first thing to understand about the question. No blood test measures filtration directly. The standard tests measure waste, then infer filtration from how much waste is accumulating. Each inference has a weak spot, which is why there are three numbers and not one.

The three numbers on a standard panel

1. Creatinine. Creatinine is a waste product from the normal breakdown of muscle, per the National Kidney Foundation, and healthy kidneys clear it steadily. When filtration falls, creatinine rises. The MedlinePlus creatinine test overview describes it as the standard first measure. Typical adult values run roughly 0.6 to 1.3 mg/dL, as hospital references such as UCSF’s list, with the important caveat that the “normal” value depends on how much muscle you have.

2. eGFR. The estimated glomerular filtration rate converts your creatinine into a filtration estimate, adjusting for age and sex, using the current race-free equation. It is printed beside the creatinine on most reports and is the number clinicians stage disease by. The NKF’s categories: 90 or higher is normal; 60 to 89 may mean early kidney disease; 15 to 59 may mean kidney disease; below 15 may mean kidney failure. eGFR also declines with age in people without kidney disease, which is why a 75-year-old at 70 is read differently from a 30-year-old at 70. The MedlinePlus GFR test page covers the calculation.

3. BUN. Blood urea nitrogen is a waste product of protein breakdown that the kidneys also clear. It rises when filtration falls, but it also rises with dehydration, a high-protein diet, gastrointestinal bleeding, and certain medications, and it falls with liver disease and low protein intake. Typical adult values are roughly 6 to 20 mg/dL. BUN’s real job is as a companion: a high BUN with a normal creatinine usually points to dehydration rather than kidney disease, while both rising together points to the kidneys.

All three arrive in one tube of blood, inside a basic or comprehensive metabolic panel, which is why “what blood test shows kidney function” has such a short practical answer: ask for a metabolic panel, and read the eGFR.

What test shows kidney function most completely?

The honest answer is two tests, not one. The NIDDK describes kidney disease screening as a blood test for GFR plus a urine test for albumin, and it uses the same pair to monitor the disease over time.

The urine test is the albumin-to-creatinine ratio (uACR), run on a single urine sample. Albumin is a blood protein that healthy filters hold back; when it leaks into urine, the filters are damaged, often years before eGFR falls. NIDDK’s cutoff: 30 mg/g or less is normal; more than 30 may be a sign of kidney disease, and a positive is typically repeated once or twice to confirm. This is the test that catches early diabetic and hypertensive kidney damage while the blood numbers still look fine.

So the complete picture is eGFR from blood plus uACR from urine. A normal eGFR with a high uACR is kidney disease. A low eGFR with a normal uACR is also kidney disease, of a different pattern. Only both normal, on repeat, means the kidneys are in the clear.

What is the most accurate test for kidney function?

This question has two answers depending on what “accurate” is for.

The most accurate measurement is a measured GFR. The NKF distinguishes estimated GFR, a calculation from creatinine or cystatin C, from measured GFR, which tracks the clearance of a substance your body does not produce, such as iohexol (a contrast agent) or inulin. Measured GFR is the reference standard: it is what the estimating equations are validated against. It is also slow, expensive, and rarely needed, so it is reserved for situations like evaluating living kidney donors, dosing certain chemotherapy, or resolving a case where the estimates conflict.

The most accurate routine blood test is cystatin C, or better, creatinine and cystatin C together. Cystatin C is a small protein produced at a steady rate by nearly all cells, filtered by the kidneys, and not tied to muscle mass. An eGFR calculated from cystatin C sidesteps creatinine’s biggest weakness, and an eGFR that combines both markers is more accurate than either alone. Current practice, reflected in the NIDDK’s laboratory evaluation guidance for clinicians, is to confirm a creatinine-based eGFR near a decision threshold with a cystatin C-based or combined estimate before labeling someone with chronic kidney disease or changing a drug dose.

Cystatin C has its own confounders, including thyroid disease, high-dose steroids, obesity, and inflammation, which is why neither marker is perfect and the combination is preferred.

In practice: creatinine-based eGFR for screening, cystatin C to confirm, measured GFR when the stakes justify it.

Why creatinine misleads, and in whom

Creatinine comes from muscle, so creatinine-based eGFR assumes you have an average amount of it. People who do not get misread in predictable directions.

Underestimated kidney function (eGFR reads too low): bodybuilders and very muscular people, heavy creatine or protein-supplement users, and people who ate a large cooked-meat meal before the draw.

Overestimated kidney function (eGFR reads too high): older or frail adults, people with low muscle mass from illness, amputees, people with liver cirrhosis, and anyone malnourished. This group is the more dangerous one, because a reassuring eGFR can hide real impairment and lead to drug doses that are too high.

Transiently shifted: dehydration raises creatinine and BUN; some medications, including certain antibiotics and acid blockers, raise creatinine without changing true filtration; a hard workout raises it for a day or two.

If you fall into any of these groups and your eGFR surprises you, a cystatin C test is the right next step, not a diet change or a panic.

What the numbers mean together

Pattern Likely meaning Usual next step
eGFR 90+, uACR under 30 Normal Routine rechecks if at risk
eGFR 60 to 89, uACR under 30 Mildly reduced; often age-related, not disease on its own Repeat in 3 months; add uACR
eGFR 60+, uACR over 30 Kidney damage with preserved filtration Confirm uACR, treat causes, protect kidneys
eGFR under 60, confirmed over 3 months Chronic kidney disease Staging, cause workup, medication review
High BUN, normal creatinine Dehydration or high protein intake Hydrate, recheck
Sudden eGFR drop from your baseline Acute kidney injury until proven otherwise Prompt evaluation

Two rules sit under the table. First, chronic kidney disease is defined by persistence: reduced eGFR or markers of damage for at least three months, which is why the NKF advises repeating a low eGFR in three months rather than acting on one draw. Second, trend beats snapshot. Your own prior creatinine values are the best reference range you have, and a jump from 0.8 to 1.3 matters more than a stable 1.3 that has always been 1.3.

Two reports, read the right way

Case one. A 34-year-old man who lifts five days a week and takes creatine gets a metabolic panel at a physical. Creatinine 1.4 mg/dL, flagged high; eGFR 64, flagged low; BUN 17; everything else normal. Line by line, it looks like early kidney disease. In context, it looks like muscle: creatine supplementation and high muscle mass both push creatinine up, and the eGFR equation cannot tell. The right next step is a cystatin C test and a urine albumin-to-creatinine ratio. If cystatin C-based eGFR comes back at 98 and uACR is under 30, his kidneys are fine and the panel was describing his gym routine.

Case two. A 61-year-old woman with type 2 diabetes and high blood pressure has a creatinine of 0.9 and an eGFR of 72, both in range, and her clinician adds a uACR. It returns 85 mg/g, repeated at 92 a few weeks later. Her blood numbers said nothing was wrong. Her urine says the filters are leaking protein, the earliest sign of diabetic kidney damage. That finding, not the eGFR, is what starts kidney-protective medication and tighter blood pressure and sugar control while there is still full function to protect.

One man with abnormal blood tests and healthy kidneys; one woman with normal blood tests and kidney disease. The three numbers are the start of the assessment, and the two add-on tests are what make it complete.

Acute versus chronic: the question of time

The same numbers mean different things depending on how fast they changed. A creatinine that has sat at 1.2 for a decade is a stable baseline. A creatinine that was 0.8 last year and is 1.2 today has risen 50 percent and represents a real loss of filtration, even though both values are “in range.” Acute kidney injury, from dehydration, an NSAID, an infection, a contrast dye, or a urinary blockage, is defined by that kind of rapid change, and it is often reversible if caught.

Chronic kidney disease is defined by persistence: reduced eGFR or markers of damage lasting three months or longer. The three-month repeat the NKF recommends exists to separate the two, and to avoid labeling a dehydrated person with a chronic disease. The practical lesson for anyone reading a report: find your previous values. A number without a trend is half a result.

Who should be tested, and how often

The CDC’s kidney disease testing guidance and NIDDK agree on the groups at risk: diabetes, high blood pressure, heart disease, obesity, a family history of kidney failure, and age over 60. NIDDK recommends yearly testing for people with diabetes and a conversation about frequency for the others. The CDC notes that most people with kidney disease do not know they have it, because early disease has no symptoms, which is the whole argument for testing people who feel fine but carry risk factors.

For everyone else, a metabolic panel at routine physicals, which includes creatinine and eGFR, is standard. Adding a uACR is cheap and is the piece most often skipped.

Symptoms that should trigger testing regardless of risk: swelling in the legs or around the eyes, foamy urine, blood in urine, a sharp drop in urine output, or new high blood pressure. Learn more in MedlinePlus’s chronic kidney disease overview.

Preparation and what can throw it off

Hydration. Dehydration concentrates the blood and nudges creatinine and BUN upward. Drink normally before the draw.

Food. Fasting is not required for creatinine, but a large meat meal shortly before can raise it slightly. Many panels are drawn fasting anyway for the glucose line.

Exercise. Avoid a hard workout in the day or two before testing.

Supplements. Creatine raises creatinine without affecting the kidneys. Mention it, or pause it a week before the test.

Medications. NSAIDs like ibuprofen can reduce kidney function transiently; some antibiotics and acid blockers raise creatinine without changing filtration. Bring the list.

Pregnancy. Kidney filtration rises in pregnancy, so creatinine runs lower; a “normal” value for a non-pregnant adult can be abnormal for a pregnant one.

Cost and getting tested

Creatinine with eGFR comes inside any basic or comprehensive metabolic panel, which commonly runs $20 to $50 self-pay and is routinely insurance-covered at checkups, as overviews like Testing.com’s creatinine page describe. Adding a urine albumin-to-creatinine ratio typically costs $20 to $40 more; cystatin C is a separate order, often $30 to $80. MedlinePlus’s kidney tests hub lists the full family. You can compare options through August’s lab test directory.

If you have a result and are unsure whether a low eGFR reflects your kidneys or your gym habit, describing your numbers and situation to August, the free AI health assistant, can help you frame the question; it is a starting point, not a diagnosis. And to review results with a clinician, order a cystatin C or uACR, or plan the three-month recheck, August’s telehealth services can connect you with one.

Frequently Asked Questions

The creatinine test inside a basic or comprehensive metabolic panel, which also reports eGFR calculated from it and BUN alongside. If you want the complete kidney picture, ask for a urine albumin-to-creatinine ratio as well.

Cystatin C. It is produced by nearly all cells at a steady rate and does not depend on muscle mass, so an eGFR built from it, or from creatinine and cystatin C together, is more accurate in muscular, frail, elderly, or malnourished people.

A measured GFR using a tracer such as iohexol is the reference standard, used in special situations like donor evaluation. For routine care, a combined creatinine-and-cystatin C eGFR is the most accurate practical blood test, and eGFR plus a urine albumin test is the most complete assessment.

Not necessarily. It falls in the 60 to 89 band, which the NKF describes as possibly early kidney disease but which is common and often age-related, especially past 60. The standard response is a repeat in three months plus a urine albumin test; with normal albumin and a stable value, many people in that range have no kidney disease at all.

Because creatinine comes from muscle. More muscle, higher creatinine, lower calculated eGFR, with nothing wrong. Creatine supplements add to it. A cystatin C test resolves the question.

Little. BUN rises with dehydration, high protein intake, and GI bleeding as readily as with kidney disease, and falls with liver disease. Read it next to creatinine: both up together points to the kidneys, BUN up alone usually points to fluids or diet.

Yes, and it is common. Early diabetic and hypertensive kidney damage shows up as albumin in the urine while filtration is still normal. That is why NIDDK pairs the blood test with a urine albumin test rather than relying on eGFR alone.

Yearly if you have diabetes, per NIDDK; on a schedule set with your clinician for high blood pressure, heart disease, or a family history of kidney failure; and at routine physicals otherwise. A borderline result gets a repeat in about three months.

Not for creatinine itself, though many panels are drawn fasting for other components. What matters more is normal hydration, no heavy workout the day before, and mentioning creatine or protein supplements.

They answer different questions, which is why both are used. The blood test estimates how much the kidneys are filtering; the urine albumin test shows whether the filters are damaged and leaking protein. Damage usually appears in urine years before filtration falls in blood, so screening people at risk uses both.

A fast fall from your usual value suggests acute kidney injury, from dehydration, a medication, an infection, or a blockage, and it needs prompt evaluation rather than a three-month wait. The three-month rule applies to confirming chronic disease, not to sudden change.